These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2356144)

  • 1. [Examination of circulating stem cells from the granulocyte-monocyte line in patients with Hodgkin's disease].
    Lutyński A; Kuratowska Z; Meder J
    Nowotwory; 1990; 40(1):12-20. PubMed ID: 2356144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with Hodgkin's disease: a phase I/II study.
    Hovgaard DJ; Nissen NI
    J Clin Oncol; 1992 Mar; 10(3):390-7. PubMed ID: 1740678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized multicentre trial of filgrastim as an adjunct to combination chemotherapy for Hodgkin's disease. West of Scotland Lymphoma Group.
    Dunlop DJ; Eatock MM; Paul J; Anderson S; Reed NS; Soukop M; Lucie N; Fitzsimmons EJ; Tansey P; Steward WP
    Clin Oncol (R Coll Radiol); 1998; 10(2):107-14. PubMed ID: 9610900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential benefits of therapeutic splenectomy for patients with Hodgkin's disease and non-Hodgkin's lymphomas.
    Schreiber DP; Jacobs C; Rosenberg SA; Cox RS; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):31-6. PubMed ID: 3838166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy.
    van den Berg H; Stuve W; Behrendt H
    Med Pediatr Oncol; 1997 Jul; 29(1):23-7. PubMed ID: 9142201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and leukocytic bactericidal activity in the course of chemotherapy of Hodgkin's disease.
    Wysocka J; Kemona H; Prokopowicz J; Kiluk S
    Acta Med Pol; 1987; 28(1-4):99-107. PubMed ID: 3506375
    [No Abstract]   [Full Text] [Related]  

  • 7. Mopp chemotherapy in the treatment of stage IV Hodgkin's disease.
    Fiacchini M; Lauria F; Mazza P; Cantore M; Gherlinzoni F; Tura S
    Haematologica; 1985; 70(2):148-54. PubMed ID: 3924778
    [No Abstract]   [Full Text] [Related]  

  • 8. [MOPP therapy of Hodgkin's disease previously treated with MOPP].
    Frau A; Montalar J
    Med Clin (Barc); 1985 May; 84(19):801. PubMed ID: 3839875
    [No Abstract]   [Full Text] [Related]  

  • 9. MOPP chemotherapy alone: a suitable treatment for early stages of Hodgkin's disease?
    Colonna P; Andrieu JM
    Lancet; 1985 May; 1(8439):1224. PubMed ID: 2860433
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of the treatment of patients with Hodgkin's disease by the MOPP protocol in relation to the histological type of the disease].
    Krajewska B; Dziewulska-Bokiniec A; Goszczyńska-Matysiak E; Kacprzak G
    Nowotwory; 1987; 37(4):317-21. PubMed ID: 3451197
    [No Abstract]   [Full Text] [Related]  

  • 11. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
    Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
    J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CVP or C-MOPP combination chemotherapy in the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma (intermediate grade of working formulation)].
    Sampi K; Honda T; Hattori M
    Rinsho Ketsueki; 1984 Feb; 25(2):164-8. PubMed ID: 6547984
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term results.
    Hancock BW; Vaughan Hudson G; Vaughan Hudson B; Haybittle JL; Bennett MH; MacLennan KA; Jelliffe AM
    Br J Cancer; 1991 Apr; 63(4):579-82. PubMed ID: 2021542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
    Canellos GP
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MOPP therapy in children with Hodgkin's disease.
    Madanat FF
    Am J Pediatr Hematol Oncol; 1989; 11(4):407-10. PubMed ID: 2618974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hodgkin's lymphoma in children: results of treatment with the MOPP protocol and a combination of radiotherapy and chemotherapy].
    Vuković I; Janković MB; Janić D; Stojimirović E
    Srp Arh Celok Lek; 1985; 113(11-12):1013-21. PubMed ID: 3841764
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prognostic value of the results of short-term polychemotherapy by the MOPP program of Hodgkin's disease stages III and IV].
    Hansz J; Burchardt K; Komarnicki M; Trepińska E; Psuja P
    Pol Arch Med Wewn; 1984 Dec; 72(6):293-8. PubMed ID: 6549512
    [No Abstract]   [Full Text] [Related]  

  • 19. MOPP/ABV/CAD chemotherapy with and without recombinant human granulocyte-macrophage colony stimulating factor in untreated, unfavorable prognosis Hodgkin's disease.
    Riccardi A; Gobbi P; Danova M; Giordano M; Pieresca C; Bertoloni D; Brugnatelli S; Ascari E
    Haematologica; 1993; 78(1):44-8. PubMed ID: 7684012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined chemotherapy-radiotherapy in advanced Hodgkin's disease: results of a prospective clinical trial with 70 stage IIIB-IV patients.
    Fermé C; Lepage E; Brice P; D'Agay MF; Fermand JP; Castaigne S; Frija J; Miot C; Marty M; Gisselbrecht C
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):397-405. PubMed ID: 7685749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.